CERo Therapeutics Holdings, Inc. CERO shares are racing higher Thursday after the company announced the publication of preclinical research on the use of its clinical candidate CER-1236 to treat AML patients.
The Details:
The preclinical research found that the target for CER-1236 is found in 83% of leukemic cells extracted from the bone marrow from patients, and CER-1236 effectively eliminated leukemic cells in the company’s experiments.
“This new publication provides support for our plans to test CER-1236 in AML patients in our planned Phase I clinical trial, and moreover extends the scientific data we have produced showing the target for CER-1236 is present on tumor cells from diverse cancers, including ovarian, non-small cell lung cancer (NSCLC), and B cell malignancies,” said Daniel Corey M.D, Ph.D, CERo’s CTO.
Related News: Palantir Is Trending On WallStreetBets: Here’s What Retail Is Saying On Reddit
By now you're likely curious about how to participate in the market for CERo Therapeutics Hldgs CERO – be it to purchase shares, or even attempt to bet against the company.
How To Buy CERO Stock:
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the the case of CERo Therapeutics CERO, which is trading at $6.34 as of publishing time, $100 would buy you 15.15 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
CERO Price Action: According to Benzinga Pro, CERo Therapeutics shares are up 102% at $5.16 at the time of publication.
Image: Pete Linforth from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
